| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 7.4e-05 | 1 |